125 related articles for article (PubMed ID: 2161233)
21. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.
McHugh NJ; James IE; Maddison PJ
Clin Exp Immunol; 1988 Jun; 72(3):457-64. PubMed ID: 3048806
[TBL] [Abstract][Full Text] [Related]
22. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin isotype distribution of locally produced autoantibodies to collagen type I in adult periodontitis. Relationship to periodontal treatment.
Jonsson R; Pitts A; Lue C; Gay S; Mestecky J
J Clin Periodontol; 1991 Oct; 18(9):703-7. PubMed ID: 1960239
[TBL] [Abstract][Full Text] [Related]
24. The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis.
De Winter LM; Geusens P; Lenaerts J; Vanhoof J; Stinissen P; Somers V
Arthritis Res Ther; 2016 Jun; 18(1):130. PubMed ID: 27267896
[TBL] [Abstract][Full Text] [Related]
25. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
[TBL] [Abstract][Full Text] [Related]
26. Detection of anticentromere antibodies using cloned autoantigen CENP-B.
Rothfield N; Whitaker D; Bordwell B; Weiner E; Senecal JL; Earnshaw W
Arthritis Rheum; 1987 Dec; 30(12):1416-9. PubMed ID: 3435569
[TBL] [Abstract][Full Text] [Related]
27. [Investigation of immunoglobulin isotypes in patients with fasciolosis].
Demirci M; Tanyel TT; Kaya S
Mikrobiyol Bul; 2009 Jul; 43(3):471-5. PubMed ID: 19795623
[TBL] [Abstract][Full Text] [Related]
28. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
29. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
Kallenberg CG
Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
[No Abstract] [Full Text] [Related]
30. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
31. Antiglycosphingolipid immune responses in neurology. The Vienna experience with isotypes, subclasses, and disease.
Gatterbauer B; Neisser A; Bernheimer H; Schwerer B
Ann N Y Acad Sci; 1998 Jun; 845():353-62. PubMed ID: 9668368
[TBL] [Abstract][Full Text] [Related]
32. A modified ELISA for improved detection of IgA, IgG, and IgM anti-tissue transglutaminase antibodies in celiac disease.
Teesalu K; Agardh D; Panarina M; Utt M; Uibo O; Uibo R
Clin Chim Acta; 2009 May; 403(1-2):37-41. PubMed ID: 19408348
[TBL] [Abstract][Full Text] [Related]
33. Spectrotype analysis of human ABO antibodies: evidence for different clonal heterogeneity of IgM, IgG, and IgA antibody populations.
Rieben R; Frauenfelder A; Nydegger UE
Vox Sang; 1996; 70(2):104-11. PubMed ID: 8801757
[TBL] [Abstract][Full Text] [Related]
34. Induction of anticentromere antibody in patients receiving treatment with D-penicillamine.
Haberhauer G
Klin Wochenschr; 1989 May; 67(10):535-7. PubMed ID: 2786978
[TBL] [Abstract][Full Text] [Related]
35. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.
Lakos G; Kiss E; Regëczy N; Tarján P; Soltész P; Zeher M; Bodolay E; Szakony S; Sipka S; Szegedi G
Clin Exp Immunol; 1999 Sep; 117(3):574-9. PubMed ID: 10469065
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of colostrum as an alternative biological sample for the diagnosis of human congenital toxoplasmosis.
Oliveira AC; Borges HD; Carvalho FR; de Macêdo AG; Mota CM; Oliveira AM; Santiago FM; Araújo CG; Silva DA; Mineo TW; Abdallah VO; Mineo JR
BMC Infect Dis; 2015 Nov; 15():519. PubMed ID: 26573138
[TBL] [Abstract][Full Text] [Related]
37. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
Hu PQ; Fertig N; Medsger TA; Wright TM
Arthritis Rheum; 2003 May; 48(5):1363-73. PubMed ID: 12746909
[TBL] [Abstract][Full Text] [Related]
38. A cross-reactive idiotype in scleroderma.
Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of anticentromere antibody assay].
Moteki S
Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
[No Abstract] [Full Text] [Related]
40. Clinical significance of serum anti-annexin V antibodies in Egyptian patients with scleroderma.
El Serougy IM; Shahin AA; Soliman DA; Akhnoukh AF; Mousa SM
Egypt J Immunol; 2009; 16(1):1-8. PubMed ID: 20726317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
